Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines

Cancer Research

Volumn 67, Issue 23, 2007, Pages 11166-11175

  Palmer, Christopher P ^a   Mahen, Robert ^a   Schnell, Eva ^a   Djamgoz, Mustafa B A ^a   Aydar, Ebru ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; SIGMA 1 OPIATE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PURIFICATION;

ANTIGENS, CD29; ANTIPSYCHOTIC AGENTS; BIOLOGICAL TRANSPORT; BIOTIN; BREAST NEOPLASMS; CELL ADHESION; CELL MEMBRANE; CELLS, CULTURED; CHOLESTEROL; GENE SILENCING; HUMANS; KIDNEY; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; PEPTIDE FRAGMENTS; PHENAZOCINE; RECEPTORS, SIGMA; SIGNAL TRANSDUCTION;

EID: 37049016678     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1771     Document Type: Article

References (40)

1. Hancock JF. Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol 2006;7:456-62.
2. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976;197:517-32.
3. Leonard BE. Sigma receptors and σ ligands: background to a pharmacological enigma. Pharmacopsychiatry 2004;3:166-70.
4. Hanner M, Moebius FF, Flandorfer A, et al. Purification, molecular cloning, and expression of the mammalian σ1-binding site. Proc Natl Acad Sci U S A 1996;93:8072-7.
5. Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 j receptor. Biochem Biophys Res Commun 1997;241:535-40.
6. Aydar E, Palmer CP, Klyachko VA, Jackson MB. The σ receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 2002;34:399-410.
7. Aydar E, Onganer P, Perrett R, Djamgoz MB, Palmer CP. The expression and functional characterization of sigma (σ) 1 receptors in breast cancer cell lines. Cancer Lett 2006;242:245-57.
8. Hayashi T, Su TP. Regulating ankyrin dynamics: Roles of σ-1 receptors. Proc Natl Acad Sci U S A 2001;98:491-6.
9. Morin-Surun MP, Collin T, Denavit-Saubie M, Baulieu EE, Monnet FP. Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci U S A 1999;96:8196-9.
10. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, Ganapathy V. Molecular and ligand-binding characterization of the σ-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 1999;289:251-60.
11. Seth P, Ganapathy ME, Conway SJ, et al. Expression pattern of the type 1 σ receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochim Biophys Acta 2001;1540:59-67.
12. Guitart X, Codony X, Monroy X. Sigma receptors: biology and therapeutic potential. Psychopharmacology 2004;174:301-19.
13. Hashimoto K, Ishiwata K. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 2006;12:3857-76.
14. Langa F, Codony X, Tovar V, et al. Generation and phenotypic analysis of σ receptor type I (σ1) knockout mice. Eur J Neurosci 2003;18:2188-96.
15. Cendan CM, Pujalte JM, Portillo-Salido E, Montoliu L, Baeyens JM. Formalin-induced pain is reduced in σ(1) receptor knockout mice. Eur J Pharmacol 2005;511:73-4.
16. Aydar E, Palmer CP, Djamgoz MB. Sigma receptors and cancer: possible involvement of ion channels. Cancer Res 2004;64:5029-35.
17. Wang B, Rouzier R, Albarracin CT, et al. Expression of σ1 receptor in human breast cancer. Breast Cancer Res Treat 2004;87:205-14.
18. Lupardus PJ, Wilke RA, Aydar E, et al. Membrane-delimited coupling between σ receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 2000;526:527-39.
19. Zhang H, Cuevas J. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 2002;87:2867-79.
20. Gebreselassie D, Bowen WD. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. Eur J Pharmacol 2004;493:19-28.
21. Takebayashi M, Hayashi T, Su TP. Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse 2004;53:90-103.
22. Hayashi T, Su TP. N Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci U S A 2004;101:14949-54.
23. Hayashi T, Su TP. Sigma-1 receptors (σ(1) binding sites) form raft like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 2003;306:718-25.
24. Li YC, Park MJ, Ye SK, Kim CW, Kim YN. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 2006;168:1107-18.
25. Jamin N, Neumann JM, Ostuni MA, et al. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol 2005;19:588-94.
26. Vincent N, Genin C, Malvoisin E. Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim Biophys Acta 2002;1567:157-64.
27. Wichman A. Affinity chromatography of human plasma low- and high-density lipoproteins. Elution by selective cleavage of a bond in the spacer. Biochem J 1979;181:691-8.
28. Lin VC, Woon CT, Aw SE, Guo C. Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion. Endocrinology 2003;144:5650-7.
29. Huang Q, Shen HM, Shui G, Wenk MR, Ong CN. Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway. Cancer Res 2006;66:5807-15.
30. Chen Y, Hajipour AR. Sievert MK, Arbabian M, Ruoho AE. Characterization of the cocaine binding site on the σ-1 receptor. Biochemistry 2007;46:3532-42.
31. Maurice T. Neurosteroids and σ1 receptors, biochemical and behavioral relevance. Pharmacopsychiatry 2004;37:171-82.
32. Ashman WH, Barbuch RJ, Ulbright CE, Jarrett HW, Bard M. Cloning and disruption of yeast C-8 sterol isomerase gene. Lipids 1991;26:628-32.
33. Benveniste P. Sterol biosynthesis. Annu Rev Plant Physiol 1986;37:275-308.
34. Mercer EI. Sterol biosynthesis inhibitors: their current status and modes of action. Lipids 1991;26:584-97.
35. + channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 2001;276:8409-14.
36. Wong W, Schlichter LC. Differential recruitment of Kv1.4 and Kv4.2 to lipid rafts by PSD-95. J Biol Chem 2004;279:444-52.
37. Fujita T, Majikawa Y, Umehisa S, et al. Sigma Receptor ligand-induced up-regulation of the H(+)/peptide transporter PEPT1 in the human intestinal cell line Caco-2. Biochem Biophys Res Commun 1999;261:242-6.
38. Martina M, B-Turcotte ME, Halman S, Bergeron R. Sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 2007;578:143-57.
39. Gniadecki R. Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochem Biophys Res Commun 2004;320:165-9.
40. Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem 2004;91:54-69.